Mary K. Miller

1.4k total citations
34 papers, 1.0k citations indexed

About

Mary K. Miller is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mary K. Miller has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mary K. Miller's work include Asthma and respiratory diseases (11 papers), Respiratory and Cough-Related Research (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Mary K. Miller is often cited by papers focused on Asthma and respiratory diseases (11 papers), Respiratory and Cough-Related Research (5 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Mary K. Miller collaborates with scholars based in United States, Germany and United Kingdom. Mary K. Miller's co-authors include Sally E. Wenzel, Dave P. Miller, June H. Lee, Mark D. Eisner, Carlos Iribarren, Irina Tolstykh, Dennis A. Wong, Michael E. Wechsler, Lisa Lawrence-Miyasaki and Eugene R. Bleecker and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Epidemiology and CHEST Journal.

In The Last Decade

Mary K. Miller

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary K. Miller United States 16 596 484 149 112 101 34 1.0k
Arzu Yorgancıoğlu Türkiye 18 1.1k 1.8× 1.1k 2.3× 227 1.5× 115 1.0× 157 1.6× 93 1.8k
Maria Watson United States 11 532 0.9× 448 0.9× 93 0.6× 59 0.5× 190 1.9× 17 1.1k
Ginette Moores Canada 5 718 1.2× 523 1.1× 118 0.8× 101 0.9× 95 0.9× 9 1.1k
Ömür Aydın Türkiye 18 317 0.5× 285 0.6× 147 1.0× 45 0.4× 85 0.8× 81 956
Hans Christian Siersted Denmark 18 1.2k 2.1× 1.1k 2.2× 206 1.4× 168 1.5× 85 0.8× 34 1.7k
Anne Burden United Kingdom 17 1.0k 1.7× 997 2.1× 98 0.7× 91 0.8× 137 1.4× 27 1.3k
R. Brett McQueen United States 16 362 0.6× 305 0.6× 44 0.3× 86 0.8× 142 1.4× 58 1.2k
Anne Pietinalho Finland 22 1.3k 2.1× 1.2k 2.5× 93 0.6× 39 0.3× 76 0.8× 33 1.5k
Lawrence Rasouliyan United States 19 488 0.8× 1.1k 2.2× 63 0.4× 122 1.1× 58 0.6× 47 1.5k
Paweł Majak Poland 21 894 1.5× 528 1.1× 580 3.9× 103 0.9× 64 0.6× 101 1.4k

Countries citing papers authored by Mary K. Miller

Since Specialization
Citations

This map shows the geographic impact of Mary K. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary K. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary K. Miller more than expected).

Fields of papers citing papers by Mary K. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary K. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary K. Miller. The network helps show where Mary K. Miller may publish in the future.

Co-authorship network of co-authors of Mary K. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Mary K. Miller. A scholar is included among the top collaborators of Mary K. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary K. Miller. Mary K. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lu, Stephanie von Klot, Claudia A. Salinas, et al.. (2024). Adopting a Framework for Rapid Real-World Data Analyses in Safety Signal Assessment. Therapeutic Innovation & Regulatory Science. 58(6). 1014–1022.
2.
Patadia, Vaishali, Katrin Manlik, Ruth Namuyinga, et al.. (2024). Leveraging Real-World Data in Safety Signal Assessment. Therapeutic Innovation & Regulatory Science. 58(6). 1062–1070. 1 indexed citations
3.
Miller, Mary K., et al.. (2024). Change in Nutrition Behavior After Participating in an Obesity-Related Cancer Education Program in El Paso, Texas.. Cancer Control. 31. 2925679615–2925679615.
4.
5.
Miller, Mary K., et al.. (2022). Novel Use of Seraph-100™ Blood Purification Therapy in Heat Stroke. Military Medicine. 188(1-2). 407–409. 1 indexed citations
6.
Miller, Mary K., et al.. (2018). Metabolic responses to high-fat diets rich in MUFAv. PUFA. British Journal Of Nutrition. 120(1). 13–22. 23 indexed citations
7.
Miller, Mary K., et al.. (2016). A PUFA-rich diet improves fat oxidation following saturated fat-rich meal. European Journal of Nutrition. 56(5). 1845–1857. 18 indexed citations
8.
Lam, Vincent K., et al.. (2014). Community Low-Dose CT Lung Cancer Screening: A Prospective Cohort Study. Lung. 193(1). 135–139. 15 indexed citations
9.
Rath, Barbara, et al.. (2014). A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months. Pharmacoepidemiology and Drug Safety. 24(3). 286–296. 9 indexed citations
10.
Sankaran‐Walters, Sumathi, Mónica Macal, Irina Grishina, et al.. (2013). Sex differences matter in the gut: effect on mucosal immune activation and inflammation. Biology of Sex Differences. 4(1). 10–10. 113 indexed citations
11.
Schneider, Cornelia, et al.. (2013). Use of anti-malarial drugs and the risk of developing eye disorders. Travel Medicine and Infectious Disease. 12(1). 40–47. 8 indexed citations
12.
Eisner, Mark D., James L. Zazzali, Mary K. Miller, Mary S. Bradley, & Michael Schätz. (2012). Longitudinal Changes in Asthma Control with Omalizumab: 2-Year Interim Data from the EXCELS Study. Journal of Asthma. 49(6). 642–648. 24 indexed citations
13.
Iribarren, Carlos, Irina Tolstykh, Mary K. Miller, & Mark D. Eisner. (2010). Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Annals of Allergy Asthma & Immunology. 104(5). 371–377.e2. 54 indexed citations
14.
Long, Aidan A., James E. Fish, Abdelkader Rahmaoui, et al.. (2009). Baseline characteristics of patients enrolled in EXCELS: a cohort study. Annals of Allergy Asthma & Immunology. 103(3). 212–219. 40 indexed citations
15.
Scheuerle, Angela E., Vani Vannappagari, & Mary K. Miller. (2009). Measurements of birth defect prevalence: Which is most useful as a comparator group for pharmaceutical pregnancy registries?. Birth Defects Research Part A Clinical and Molecular Teratology. 85(7). 611–620. 5 indexed citations
16.
Wechsler, Michael E., Dennis A. Wong, Mary K. Miller, & Lisa Lawrence-Miyasaki. (2009). Churg-Strauss Syndrome in Patients Treated With Omalizumab. CHEST Journal. 136(2). 507–518. 90 indexed citations
17.
Taylor, Lee, Mary K. Miller, Tracey H. Joffe, et al.. (2009). Palliative care in Yorkshire, UK 1987-2008: survival and mortality in a hospice. Archives of Disease in Childhood. 95(2). 89–93. 23 indexed citations
18.
Sylaja, PN, Wei Dong, James C. Grotta, et al.. (2007). Safety outcomes of Alteplase among acute ischemic stroke patients with special characteristics. Neurocritical Care. 6(3). 181–185. 10 indexed citations
19.
Miller, Mary K., June H. Lee, Dave P. Miller, & Sally E. Wenzel. (2006). Recent asthma exacerbations: A key predictor of future exacerbations. Respiratory Medicine. 101(3). 481–489. 215 indexed citations
20.
Miller, Mary K.. (1995). Space Makes Strange Bedfellows. The Sciences. 35(3). 12–15. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arzu Yorgancıoğlu Breakdown of academic impact, for papers by Maria Watson Breakdown of academic impact, for papers by Ginette Moores Breakdown of academic impact, for papers by Ömür Aydın Breakdown of academic impact, for papers by Hans Christian Siersted Breakdown of academic impact, for papers by Anne Burden Breakdown of academic impact, for papers by R. Brett McQueen Breakdown of academic impact, for papers by Anne Pietinalho Breakdown of academic impact, for papers by Lawrence Rasouliyan Breakdown of academic impact, for papers by Paweł Majak
Rankless by CCL
2026